Elsevier

Surgical Oncology

Volume 21, Issue 3, September 2012, Pages 216-222
Surgical Oncology

Review
Skeletal metastases – The role of the orthopaedic and spinal surgeon

https://doi.org/10.1016/j.suronc.2012.04.001Get rights and content

Abstract

Developments in oncological and medical therapies mean that life expectancy of patients with metastatic bone disease (MBD) is often measured in years. Complications of MBD may dramatically and irreversibly affect patient quality of life, making the careful assessment and appropriate management of these patients essential.

The roles of orthopaedic and spinal surgeons in MBD generally fall into one of four categories: diagnostic, the prophylactic fixation of metastatic deposits at risk of impending fracture (preventative surgery), the stabilisation or reconstruction of bones affected by pathological fractures (reactive surgery), or the decompression and stabilisation of the vertebral column, spinal cord, and nerve roots.

Several key principals should be adhered to whenever operating on skeletal metastases. Discussions should be held early with an appropriate multi-disciplinary team prior to intervention. Detailed pre-assessment is essential to gauge a patient’s suitability for surgery – recovery from elective surgery must be shorter than the anticipated survival. Staging and biopsies provide prognostic information. Primary bone tumours must be ruled out in the case of a solitary bone lesion to avoid inappropriate intervention. Prophylactic surgical fixation of a lesion prior to a pathological fracture reduces morbidity and length of hospital stay. Regardless of a lesion or pathological fracture’s location, all regions of the affected bone must be addressed, to reduce the risk of subsequent fracture. Surgical implants should allow full weight bearing or return to function immediately. Post-operative radiotherapy should be utilised in all cases to minimise disease progression.

Spinal surgery should be considered for those with spinal pain due to potentially reversible spinal instability or neurological compromise. The opinion of a spinal surgeon should be sought early, as delays in referral directly correlate to worse functional recovery following intervention. Patients who suffer a slowly progressive deficit, present within hours of complete neurological deficit, or have compression caused by bone alone are those most likely to benefit from surgery. Back pain in the presence of MBD should be regarded as impending spinal cord compression, and investigated urgently to allow intervention prior to the development of neurological compromise.

Introduction

Metastatic bone disease forms the final common pathway of many malignancies. Bone is the third commonest site of metastases after the lungs and liver. At post mortem 84% of patients with breast or prostate cancer have some form of skeletal deposits [1]. Patients with thyroid, lung and renal cancer have metastases in 50%, 44% and 37% respectively [2].

Although metastatic bone disease (MBD) seldom causes fatalities directly, it often dramatically and deleteriously affects quality of life. As oncological treatments have developed, life expectancy for patients with MBD has improved. Prognosis has been well reported; the median survival following diagnosis of MBD in patients with breast and prostate cancer is more than 2 and 3 years respectively [3], [4]. During this time patients are at significant risk of suffering skeletal related complications. This makes their appropriate management essential.

Advances in the fields of orthopaedic and spinal surgery mean many surgical options are available to treat skeletal metastases. Despite this the general levels of understanding of the role of surgery in MBD remain low. This unfortunately inevitably translates into the delayed or under-referral of patients that may benefit from surgery [5], [6].

This review outlines the role of orthopaedic and spinal surgeons in the management metastatic lesions of the appendicular skeleton and spine. We discuss the general principles of metastatic bone surgery, and some of the prophylactic, reactive and emergency scenarios where referral for consideration of surgery is appropriate. We also discuss the role of imaging, diagnosis and staging preoperatively, and propose which patients should be referred for an orthopaedic or spinal opinion, and those which are unlikely to benefit.

Section snippets

Assessment of patients with skeletal metastases

Patients with MBD typically present to orthopaedic or spinal surgeons acutely (following a pathological fracture or the development of neurological compromise) or semi-electively (for consideration of prophylactic surgical stabilisation.) In both scenarios a detailed assessment should be performed, including a history, examination, appropriate investigations and imaging, and sometimes a biopsy. This allows a definitive diagnosis to be made, and accurate staging to take place that provides

Overview

Surgical management of metastatic bone disease should be approached via a multidisciplinary team. Because patients with MBD may present in several ways, to a wide variety of specialities, a coordinated response with efficient liaison is therefore essential.

The roles of orthopaedic and spinal surgery in the management of metastatic bone disease fall generally into one of three categories: the prophylactic fixation of metastatic deposits at risk of impending fracture (preventative surgery), the

Prophylactic surgery

Referral of patients at risk of fracture for prophylactic surgery results in a reduction of patient morbidity, length of hospital stay and maximises quality of life. Appropriate patient selection is paramount. Patients with slowly growing primary malignancies appear to recover well from prophylactic procedures [28]. In contrast, the presence of visceral, cerebral or multiple skeletal metastases, a poor ECOG status, and the use of previous chemotherapy all reduce survival rate [35]. Accurate

Reactive surgery

Despite evidence that prophylactic surgery is preferential (with prophylactic stabilisation being technically easier and less traumatic for patients), up to one third of patients with skeletal metastases suffer pathological fractures [39]. Metastatic bones are weak, and fractures rarely unite even when stabilised appropriately. In spite of this a good functional outcome can be achieved when surgery is implemented appropriately. Denying surgical treatment should be avoided if at all possible, as

Metastatic disease of the spine

The spine is the commonest site for MBD. Up to 70% of cancer patients develop metastatic disease. Of these, 40% develop spinal metastatic disease, and 10–20% of these will develop metastatic spinal cord compression (MSCC). Compression most commonly affects the thoracic region (70%) followed by the lumbar (20%) and the cervical spine (10%) [40]. Neurological compression occurs either by direct extension of a metastatic deposit or through a pathological fracture or vertebral instability. This

Complications of orthopaedic and spinal surgery

Patients with metastatic bone disease are particularly susceptible to the general risks of surgery and anaesthesia. Pre-operative assessment by an experienced anaesthetist and the availability of high-dependency beds are essential. Complications specific to orthopaedic surgery should also be recognised. Fat Emboli Syndrome (FES) or tumour emboli can follow surgery on the long bones, particularly where the medullary canal has been reamed. Fat microemboli cause pulmonary and cerebral

Summary

Patients with skeletal metastases must be managed appropriately to ensure life expectancy and quality of life are maximised. Early recognition of metastatic bone disease and appropriate referral to an orthopaedic or spinal surgeon is often paramount to enable this. Patients with cancer and symptoms of skeletal metastases should be investigated urgently. Clinicians have many imaging modalities available to them, each with specific indications and advantages.

Definitively diagnosing a skeletal

Key messages

  • Management of MBD is the domain of the site specific MDT but each trust should have an orthopaedic lead clinician for MBD

  • Bone pain in the cancer patient should be taken seriously and investigated

  • Impending fractures are easier to treat than established fractures and the recovery is swifter

  • Back pain in the presence of MBD should be regarded as impending spinal cord compression and managed appropriately

  • Pain precedes neurological compromise in most cases of MSCC

  • Increased awareness of surgical

Conflict of interest statement

None declared.

Funding

No funds were received in support of this study.

Authorship statement

Guarantor of the integrity of the study: Ashford

Study concepts: Ashford

Study design: Eastley/Ashford

Literature research: Eastley

Manuscript preparation: Eastley/Ashford/Newey

Manuscript editing: Eastley/Ashford/Newey

Manuscript review: Eastley/Ashford/Newey

References (45)

  • D.S. O’Donoghue et al.

    Orthopaedic management of structurally significant bone disease in breast cancer metastases

    (2011)
  • E. Gosfield et al.

    Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases

    J Nucl Med

    (1993)
  • M.V. Merrick et al.

    Evaluation and skeletal metastases

    Br J Radiol

    (1992)
  • C.S. Galasko

    Skeletal metastases and mammary cancer

    Ann R Coll Surg Engl

    (1972)
  • S.S. Nathan et al.

    Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care

    J Clin Oncol

    (2005)
  • S. Eustace et al.

    A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases

    Am J Roentgenol

    (1997)
  • M.M. Steinborn et al.

    Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system

    J Comput Assist Tomogr

    (1999)
  • T. Tamada et al.

    Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer

    Br J Radiol

    (2000)
  • J.A. Frank et al.

    Detection of malignant bone tumors: MR imaging vs scintigraphy

    AJR Am J Roentgenol

    (1990)
  • F.A. Aitchison et al.

    Vertebral metastases and an equivocal bone scan: value of magnetic resonance imaging

    Nucl Med Commun

    (1992)
  • P. Theissen et al.

    Magnetic resonance imaging in screening for bone metastasis? A prospective comparison with bone scintigraphy

    Nuklearmedizin

    (1994)
  • G.P. Schmidt et al.

    Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT

    Eur Radiol

    (2007)
  • Cited by (54)

    • Alternate modalities for palliation

      2023, Palliative Radiation Oncology
    • Palliative radiation

      2023, Palliative Radiation Oncology
    • Use of endoprostheses for proximal femur metastases results in a rapid rehabilitation and low risk of implant failure A prospective population-based study

      2019, Journal of Bone Oncology
      Citation Excerpt :

      Treating metastatic bone disease (MBD) is in most cases a matter of preserving quality of life (QoL) for patients at their end of life [1,2].

    • Metastatic fractures of long limb bones

      2017, Orthopaedics and Traumatology: Surgery and Research
    View all citing articles on Scopus
    View full text